Clinical Social Workers in Mardela Springs, MD Accepting Medicare
6 Clinical Social Workers found. Showing 1 - 6
 Jason Harry Sammons, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 23704 Ocean Gtwy, Mardela Springs, MD 21837 Phone: 410-742-7400 Fax: 410-742-6452 |
 Samantha Gail Daneman, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23704 Ocean Gtwy, Mardela Springs, MD 21837 Phone: 410-742-7400 |
Miss Julie Johnson, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23704 Ocean Gtwy, Mardela Springs, MD 21837 Phone: 410-742-7400 Fax: 410-742-6452 |
Angela L Ford, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23704 Ocean Gtwy, Mardela Springs, MD 21837 Phone: 410-677-0202 |
Mrs. Blair Catlin Brown, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23704 Ocean Gtwy, Mardela Springs, MD 21837 Phone: 410-422-2545 Fax: 410-677-0303 |
Miss Tonya O'hara, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23704 Ocean Gtwy, Mardela Springs, MD 21837 Phone: 410-742-7400 Fax: 410-742-6452 |
News Archive
YM Biosciences to present JAK1/2 inhibiting small molecule and vascular disrupting agent data at Cancer Conference
YM BioSciences Inc., is presenting posters on its JAK1/2 inhibiting small molecule (CYT387) and on its novel vascular disrupting agent (CYT997) at the Lorne Cancer Conference in Lorne, Victoria, Australia. CYT387 is an oral JAK1/2 inhibitor, originating from the seminal discovery of JAK1 and JAK2 kinases by Dr. Andrew Wilks, the founder of Cytopia Limited, now YM Australia. CYT997 is an orally-available agent with dual mechanisms of vascular disruption and cytotoxicity and has the potential to be broadly active against a range of tumor types.
New probe for identifying chemical process affected proteins functions like GPS
Scientists in Michigan are reporting the development of a powerful new probe for identifying proteins affected by a key chemical process important in aging and disease. The probe works like a GPS or navigation system for finding these proteins in cells. It could lead to new insights into disease processes and identify new targets for disease treatments, the researchers say. Their study is scheduled for the Sept. 18 issue of ACS Chemical Biology, a monthly journal.
Today's Opinions: Haiti's lesson for the U.S.; Ending 'Pay for delay;' Getting the CLASS Act off the ground
In February, a month after Haiti's earthquake, I went down to Port-au-Prince as part of a team that was helping to reactivate cardiac care in the city's public hospital. For several months since, I have observed how the earthquake and its aftermath profoundly changed Haiti's health care system. Over that time, I have come to the unorthodox conclusion that Haiti's tragic experience may show us a way to improve health care in the United States (James Wilentz, 7/28).
Lixte receives $244,479.25 U.S. government grant for QTDP program
Lixte Biotechnology Holdings announced today that the company has received a $244,479.25 grant under the Qualifying Therapeutic Discovery Project.
Study results suggest reexamination of biological, medical importance of X chromosome
Painstaking new analysis of the genetic sequence of the X chromosome—long perceived as the "female" counterpart to the male-associated Y chromosome—reveals that large portions of the X have evolved to play a specialized role in sperm production.
› Verified 6 days ago